Silence Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio7.5121.2325.2842.5381.67
P/B Ratio2.4230.5420.5861.9349.39
Price/Tangible Book2.6157.6633.06580.25487.96
Price/FCF96.09
Price/OCF77.58
Enterprise Value Ratios
EV/Revenue3.5218.9720.6736.4073.34
EV/FCF82.24
Profitability & Returns
Return on Equity (ROE)-0.58%-2.23%-2.73%-4.48%-2.17%
Return on Assets (ROA)-0.19%-0.26%-0.26%-0.31%-0.29%
Return on Capital Employed (ROCE)-0.27%-0.54%-0.50%-0.56%-0.51%
Leverage & Solvency Ratios
Debt/Equity0.000.020.020.020.04
Debt/FCF0.03
Liquidity Ratios
Current Ratio11.144.624.415.692.99
Quick Ratio10.364.154.035.412.77
Efficiency Ratios
Asset Turnover0.270.250.180.140.08
Yield & Distribution Ratios
Earnings Yield-0.14%-0.08%-0.09%-0.07%-0.07%
FCF Yield-0.21%-0.07%-0.10%0.01%-0.03%
Buyback Yield-0.25%-0.15%-0.09%-0.09%-0.09%